Xueya Wu

ORCID: 0000-0002-0767-6818
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Corneal surgery and disorders
  • Ophthalmology and Visual Impairment Studies
  • Retinopathy of Prematurity Studies
  • Advancements in Battery Materials
  • Liver Diseases and Immunity
  • Natural product bioactivities and synthesis
  • Dermatology and Skin Diseases
  • Liver physiology and pathology
  • Psoriasis: Treatment and Pathogenesis
  • Bone and Dental Protein Studies
  • Phosphorus and nutrient management
  • Bone Metabolism and Diseases
  • Autoimmune Bullous Skin Diseases
  • Liver Disease Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Circular RNAs in diseases
  • Click Chemistry and Applications
  • S100 Proteins and Annexins
  • Wastewater Treatment and Nitrogen Removal
  • Metal complexes synthesis and properties
  • Breast Cancer Treatment Studies
  • Constructed Wetlands for Wastewater Treatment
  • Estrogen and related hormone effects
  • Graphene research and applications
  • MicroRNA in disease regulation

Xinxiang Medical University
2023

First Hospital of Shijiazhuang
2023

Sun Yat-sen University
2022

Harbin Medical University
2018-2021

Third Affiliated Hospital of Harbin Medical University
2018-2021

Affiliated Hospital of Chengde Medical College
2015

Hebei Normal University
2014

Efficacy of clinical chemotherapeutic agents depends not only on direct cytostatic and cytotoxic effects but also involves in eliciting (re)activation tumour immune effects. One way to provoke long-lasting antitumour immunity is coined as immunogenic cell death (ICD), exploiting the host system against cells a "second hit". Although metal-based complexes hold promise potential agents, ruthenium (Ru)-based ICD inducers remain sparse. Herein, we report half-sandwich complex Ru(II) bearing...

10.1002/cmdc.202300131 article EN ChemMedChem 2023-05-25

To evaluate eye use behavior in myopic and non-myopic children objectively using Clouclip M2 device subjectively questionnaire compare the results. The study also aimed to assess relationships between ocular biometric parameters refractive status.Clouclip was used monitoring visual environment aged 9-11 years. participants were monitored for 7 days. On eighth day, data stored collected, relevant examination conducted survey administered. paired sample t-test obtained subjectively. status...

10.3389/fped.2023.1228257 article EN cc-by Frontiers in Pediatrics 2023-08-07

To investigate refractive development and prevalence of myopia in children aged 3-6 years Hebei Province, China, to explore the developmental law refraction, so as clinically guide prediction intervention myopia.In May 2019, a total 6120 people were inspected 68 kindergartens 11 cities Province. Child refraction was checked under noncycloplegia using handheld binocular vision screener (SW-800, SUOER, Tianjin, China). Axial length (AL) corneal radius curvature (CR) measured an ocular biometry...

10.1155/2021/3656831 article EN Computational and Mathematical Methods in Medicine 2021-12-16

Ultrasonic treatment is an effective method to disintegrate sludge and extract organic matter nutrients, including nitrogen phosphorus, from the sludge. This study investigated transformation of phosphorus species during ultrasonic sludge, reveal mechanism migration in activated structure. The experimental results indicated that power density time were critical parameters affecting energy input for integration. optimal release performance was achieved at 2.5 W/mL 10 min. showed as a...

10.3390/su141811224 article EN Sustainability 2022-09-07

Tamoxifen (TAM) is the most commonly used adjuvant endocrine drug for hormone receptor-positive (HR+) breast cancer patients. However, how to accurately evaluate risk of recurrence and metastasis after TAM therapy still a major concern. In recent years, many studies have shown that clinical outcomes TAM-treated patients are influenced by activity some cytochrome P450 (CYP) enzymes catalyze formation active metabolites like endoxifen 4-hydroxytamoxifen. this study, we aimed first develop...

10.3389/fonc.2021.738222 article EN cc-by Frontiers in Oncology 2021-11-19
Coming Soon ...